Antineoplastic AgentsBreastBreast NeoplasmsCell Line, TumorAntineoplastic Agents, PhytogenicCarcinoma, Ductal, BreastReceptors, EstrogenLeukemia P388Drug Screening Assays, AntitumorTumor Cells, CulturedDoxorubicinAmaryllidaceae AlkaloidsAntibiotics, AntineoplasticNeoplasmsBreast DiseasesReceptor, erbB-2EllipticinesNarcissusBibenzylsTamoxifenGene Expression Regulation, NeoplasticReceptors, ProgesteroneAntineoplastic Combined Chemotherapy ProtocolsMammographyDrug Resistance, NeoplasmApoptosisNeoplasm MetastasisPaclitaxelMice, NudePrognosisAntineoplastic Agents, AlkylatingNeoplasm InvasivenessFluorouracilBryostatinsThiadiazinesCell ProliferationTumor Markers, BiologicalCisplatinCell SurvivalDrug SynergismAntineoplastic Agents, HormonalXenograft Model Antitumor AssaysBreast Neoplasms, MaleOvarian NeoplasmsLung NeoplasmsCell DivisionNeoplasm ProteinsNeoplasm StagingEarly Detection of CancerMastectomyDose-Response Relationship, DrugRisk FactorsAncitabineGenes, BRCA1PostmenopauseGalliumRNA, MessengerChemotherapy, AdjuvantDepsipeptidesCarcinoma, LobularNeoplasm TransplantationAntimetabolites, AntineoplasticProstatic NeoplasmsTime FactorsEpothilonesCell CycleCyclophosphamideCarcinoma, Intraductal, NoninfiltratingMCF-7 CellsMammary Neoplasms, ExperimentalSurvival AnalysisGenetic Predisposition to DiseaseCarcinoma6-MercaptopurineCase-Control StudiesBreast FeedingColonic NeoplasmsPremenopauseEstrogen Receptor alphaTreatment OutcomeEstrogensMolecular StructureDrug Administration ScheduleAminoacridinesImmunohistochemistryGene Expression ProfilingBreast Self-ExaminationMethotrexateDisease-Free SurvivalNeoplasms, Hormone-DependentRiskLymphatic MetastasisClinical Trials as TopicSarcoma 180Reverse Transcriptase Polymerase Chain ReactionFollow-Up StudiesSurvival RateNeoplasm Recurrence, LocalMenopauseBRCA2 Protein